EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tea Beverage-Dependent Reduction in Risperidone Concentration Following Mixing with Risperidone Oral Solution

Hiroyuki Suzuki, Yosuke Nishikawa, Shurito Odashima, Taisuke Konno, Ryusuke Ouchi, Daisuke Kikuchi, Kensuke Usui, Kouji Okada, Shigeki Kisara, Hitoshi Nakamura, Yuriko Murai

Scientia Pharmaceutica · 18.08.2026 · 94 (3) · 68

DOI: 10.3390/scipharm94030068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Scientia Pharmaceutica, online erschienen am 18.08.2026. Verfasst von Hiroyuki Suzuki und 10 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Risperidone (RIS) oral solution has a bitter taste and is sometimes mixed with beverages to improve palatability and medication adherence. Although the package insert advises against mixing with tea beverages, the effects of beverage type and tea leaf variety on RIS concentration remain unclear. RIS oral solution was mixed with commercially available black tea, green tea, and hojicha beverages, and black tea leaf extracts. RIS concentration in the supernatant was quantified by high-performance liquid chromatography, and its recovery from precipitates was evaluated in selected samples. RIS concentration decreased in all black tea and green tea beverages and black tea extracts, whereas some hojicha beverages showed no significant decrease. The extent of reduction differed among beverage types and black tea leaf varieties. RIS was substantially recovered from precipitates redissolved in methanol or dissolution test fluid 1 (pH 1.2), whereas recovery from dissolution test fluid 2 (pH 6.8) was lower. Chromatographic and UV spectral analyses supported the presence of RIS in redissolved precipitates. The reduction in RIS concentration is associated, at least in part, with transfer into precipitates and depends on beverage type and tea leaf variety. These findings support the recommendation to avoid diluting RIS oral solution with tea beverages.

Zitieren

APA

Suzuki, H., Nishikawa, Y., Odashima, S., Konno, T., Ouchi, R., Kikuchi, D., Usui, K., Okada, K., Kisara, S., Nakamura, H., & Murai, Y. (2026). Tea Beverage-Dependent Reduction in Risperidone Concentration Following Mixing with Risperidone Oral Solution. Scientia Pharmaceutica, 94(3), 68. https://doi.org/10.3390/scipharm94030068

Vancouver

Suzuki H, Nishikawa Y, Odashima S, Konno T, Ouchi R, Kikuchi D, et al. Tea Beverage-Dependent Reduction in Risperidone Concentration Following Mixing with Risperidone Oral Solution. Scientia Pharmaceutica. 2026;94(3):68. doi:10.3390/scipharm94030068

BibTeX
@article{Suzuki2026,
  author = {Suzuki, Hiroyuki and Nishikawa, Yosuke and Odashima, Shurito and Konno, Taisuke and Ouchi, Ryusuke and Kikuchi, Daisuke and Usui, Kensuke and Okada, Kouji and Kisara, Shigeki and Nakamura, Hitoshi and Murai, Yuriko},
  title = {Tea Beverage-Dependent Reduction in Risperidone Concentration Following Mixing with Risperidone Oral Solution},
  journal = {Scientia Pharmaceutica},
  year = {2026},
  volume = {94},
  number = {3},
  pages = {68},
  doi = {10.3390/scipharm94030068}
}
Kostenlos starten →